Kardium
Kevin Chaplin, CEO of Kardium, joins Nasdaq's Kristina Ayanian to share more about the atrial fibrillation market and how their business has a unique approach to solving an issue millions of people face.
Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowKevin Chaplin, CEO of Kardium, joins Nasdaq's Kristina Ayanian to share more about the atrial fibrillation market and how their business has a unique approach to solving an issue millions of people face.